A peer-level look at how surgeons are extending postoperative observation beyond the hospital, which digital signals they value most, how alerts translate into clinical action, and why workflow, ownership, cost, and data burden still determine whether monitoring scales.
Audience: Surgeons
Countries: 6
Completion Rate: 72.1%
SGID: 8976297
-Hero findings
– Quick Read — Key Findings
Shorter hospital stays, virtual follow-up, connected devices, wound images, recovery apps, and patient-reported data are creating more ways to observe recovery after discharge. For surgeons, however, the value of digital monitoring depends less on the amount of data collected than on whether the signal is clinically meaningful and connected to a clear response.
A 2024 JAMA Network Open systematic review and meta-analysis of perioperative telemedicine in abdominal surgery found lower readmission and emergency-department visits with digital interventions, though complication rates were not significantly different, a distinction that matters: remote monitoring may strengthen surveillance and access without automatically preventing the complication itself. The MDForLives survey reflects the same tension: surgeons report growing use of digital monitoring, yet the strongest barriers sit in evidence, reimbursement, integration, alert burden, staffing, and responsibility for follow-up.
36.5% say their use of digital technology for postoperative monitoring has increased significantly over the past three years, while another 35.7% report a moderate increase.
Digital follow-up is no longer peripheral in many surgical practices, yet the remaining 27.8% report little change, which points to uneven implementation across settings, procedures, and care models. Use also spans different functions rather than one dominant technology: recovery apps and virtual follow-up lead, followed by wearable or physiological monitoring, AI/EHR-linked surveillance, and digital wound monitoring.
57.4% select virtual follow-up and patient-reported outcome tracking as technology that could meaningfully improve postoperative monitoring; 51.9% choose integrated platforms combining multiple monitoring technologies.
The preference is notable because it does not point only toward more sensors: patient-reported recovery and virtual contact remain central, and integrated platforms rank above stand-alone continuous physiological monitoring. That reflects a surgical reality, since a change in pain, appetite, mobility, wound appearance, or symptom trajectory can matter as much as any single physiological value, and each signal is only useful when the team can see the broader recovery context.
65.7% most value earlier identification of surgical-site or wound complications, closely followed by bleeding, cardiovascular, or respiratory deterioration at 63.9%.
The top two selections are conditions where a new signal can change the urgency of assessment, and digital wound images, symptoms, vital signs, or trend data can narrow the time between a patient’s deterioration at home and the team’s awareness of it. But a digital alert does not determine the diagnosis: surgeons commonly use monitoring as an earlier prompt for contact and assessment rather than as a substitute for clinical evaluation.
46.7% say their most common next step is to contact the patient or arrange further assessment; 33.6% arrange urgent in-person review, testing, or imaging.
34.6% say postoperative alerts or patient-generated data are primarily reviewed by the operating surgeon or surgical team; 33.6% point to nursing, APP, or dedicated RPM/virtual-care teams.
The near-even split suggests there is no single operating model: in some services the surgeon remains the monitoring endpoint, while in others virtual-care teams or advanced-practice staff filter signals before surgical review. That design matters because the workload effect is mixed, 29.0% report no meaningful change, 26.2% increased workload, 23.4% reduced workload, and 21.5% say it is too early to tell or they are not yet using it.
54.2% cite limited evidence, cost, or reimbursement; 51.4% identify workflow integration, interoperability, or data-security issues.
No single issue dominates the barrier profile: a technology can be clinically promising and still fail if it sits outside the EHR, produces too many low-value alerts, lacks reimbursement, depends on staff who do not exist, or asks patients to follow a complex process after discharge. The same point appears in the utility question, where 47.7% say technology-generated data mainly supports or confirms clinical assessment and only 12.1% say it frequently changes management.
Surgeons are already working with digital recovery apps, wearable monitoring, virtual follow-up, AI-linked surveillance, and wound imaging, and the opportunity is clearest when these tools shorten the time to recognition of wound problems or physiological deterioration and make it easier to decide who needs assessment. But the data also exposes the implementation gap: a program has to assign ownership, define escalation, fit existing systems, control alert volume, support patients at home, and make economic sense, or more monitoring simply transfers work from the ward to the inbox.
The most useful future model may therefore be an integrated one: objective trends, patient-reported recovery, wound information, and virtual contact brought together in a pathway where every signal has a reviewer and every concerning pattern has a next step.
You have read the summary
Direct answers to common questions around this topic.
Direct answers to the questions healthcare professionals are most likely to ask about these findings.
